Myb proteins regulate the expression of diverse target genes

Oncogene

Volumn 24, Issue 8, 2005, Pages 1375-1384

  Lang, Georgina ^a   White, Jonathan R ^a,b   Argent Katwala, Mary J G ^a,c   Allinson, Christopher G ^a   Weston, Kathleen ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b OSI Pharmaceuticals   (United Kingdom)

^c Decision Resources Intl   (United Kingdom)

Author keywords

B Myb; c Myb; Hematopoiesis; T cell; Transcription

Indexed keywords

PROTEIN MYB; TRANSCRIPTION FACTOR;

ARTICLE; CELL LINEAGE; CLINICAL PROTOCOL; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKEMIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VALIDATION PROCESS;

ANIMALS; BASE SEQUENCE; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HEMATOPOIESIS; LEUKEMIA; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYB; TRANSCRIPTION FACTORS;

EID: 14844302391     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208301     Document Type: Article

References (61)

1. Adachi Y, Pavlakis GN and Copeland TD. (1994). J. Biol. Chem., 269, 2258-2262.
2. Allen RD, Bender TP and Siu G. (1999). Genes Dev., 13, 1073-1078.
3. Aramburu J, Heitman J and Crabtree GR. (2004). EMBO Rep., 5, 343-348.
4. Badiani P, Corbella P, Kioussis D, Marvel J and Weston K. (1994). Genes Dev., 8, 770-782.
5. Bartley PA, Lutwyche JK and Gonda TJ. (2001). Blood Cells Mol. Dis., 27, 409-415.
6. Bender TP, Kremer CS, Kraus M, Buch T and Rajewsky K. (2004). Nat. Immunol., 5, 721-729.
7. Bergholtz S, Andersen TO, Andersson KB, Borrebaek J, Luscher B and Gabrielsen OS. (2001). Nucleic. Acids Res., 29, 3546-3556.
8. Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, Kerkhoven RM, Madiredjo M, Nijkamp W, Weigelt B, Agami R, Ge W, Cavet G, Linsley PS, Beijersbergen RL and Bernards R. (2004). Nature, 428, 431-437.
9. Bies J, Hoffman B, Amanullah A, Giese T and Wolff L. (1996). Oncogene, 12, 355-363.
10. Bies J, Mukhopadhyaya R, Pierce J and Wolff L. (1995). Cell Growth Differ., 6, 59-68.
11. Bies J and Wolff L. (1995). Cancer Res., 55, 501-504.
12. Boyd KE and Farnham PJ. (1999). Proc. Soc. Exp. Biol. Med., 222, 9-28.
13. Briggs MW and Sacks DB. (2003). EMBO Rep., 4, 571-574.
14. Chan VS, Wong C and Ohashi PS. (2002). Eur. J. Immunol., 32, 1223-1229.
15. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH and Ballard DW. (1997). Proc. Natl. Acad. Sci. USA, 94, 10057-10062.
16. Clarke D, Vegiopoulos A, Crawford A, Mucenski M, Bonifer C and Frampton J. (2000). Oncogene, 19, 3343-3351.
17. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM and Strober W (eds) (1991). Current Protocols in Immunology. Greene Publishing Associates: New York.
18. Derrien V, Couillault C, Franco M, Martineau S, Montcourrier P, Houlgatte R and Chavrier P. (2002). J. Cell Sci., 115, 2867-2879.
19. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS and Reed JC. (1998). EMBO J., 17, 2215-2223.
20. Emambokus N, Vegiopoulos A, Harman B, Jenkinson E, Anderson G and Frampton J. (2003). EMBO J., 22, 4478-4488.
21. Fan Z, Beresford PJ, Oh DY, Zhang D and Lieberman J. (2003). Cell, 112, 659-672.
22. Frampton J, Ramqvist T and Graf T. (1996). Genes Dev., 10, 2720-2731.
23. Gautreau A, Louvard D and Arpin M. (2002). Curr. Opin. Cell Biol., 14, 104-109.
24. Gumbiner BM. (2000). J. Cell Biol., 148, 399-404.
25. Hogg A, Schirm S, Nakagoshi H, Bartley P, Ishii S, Bishop JM and Gonda TJ. (1997). Oncogene, 15, 2885-2898.
26. Howe KM and Watson RJ. (1991). Nucleic. Acids Res., 19, 3913-3919.
27. Iwanaga Y and Jeang KT. (2002). Cancer Res., 62, 2618-2624.
28. Kagey MH, Melhuish TA and Wotton D. (2003). Cell, 113, 127-137.
29. Klempnauer K-H, Ramsay G, Bishop JM, Moscovici MG, Moscovici C, McGrath JP and Levinson AD. (1983). Cell, 33, 345-355.
30. Kumar A, Baker SJ, Lee CM and Reddy EP. (2003). Mol. Cell Biol., 23, 6631-6645.
31. Lagaudriere-Gesbert C, Le Naour F, Lebel-Binay S, Billard M, Lemichez E, Boquet P, Boucheix C, Conjeaud H and Rubinstein E. (1997). Cell Immunol., 182, 105-112.
32. Lauder A, Castellanos A and Weston K. (2001). Mol. Cell Biol., 21, 5797-5805.
33. Lei W, Rushton JJ, Davis LM, Liu F and Ness SA. (2004). J. Biol. Chem., 279, 29519-29527.
34. Mataraza JM, Briggs MW, Li Z, Entwistle A, Ridley AJ and Sacks DB. (2003). J. Biol. Chem., 278, 41237-41245.
35. McMahon J, Howe KM and Watson RJ. (1988). Oncogene, 3, 717-720.
36. Mizejewski GJ. (1999). Proc. Soc. Exp. Biol. Med., 222, 124-138.
37. Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott Jr WJ and Potter SS. (1991). Cell, 65, 677-689.
38. Nabeshima K, Shimao Y, Inoue T and Koono M. (2002). Cancer Lett., 176, 101-109.
39. Ness SA. (2003). Blood Cells Mol. Dis., 31, 192-200.
40. Orkin SH. (2003). Immunity, 19, 633-634.
41. Quandt K, Frech K, Karas H, Wingender E and Werner T. (1995). Nucleic Acids Res., 23, 4878-4884.
42. Rantanen A, Gaspari M, Falkenberg M, Gustafsson CM and Larsson NG. (2003). Mamm. Genome, 14, 1-6.
43. Ratajczak MZ, Perrotti D, Melotti P, Powzaniuk M, Calabretta B, Onodera K, Kregenow DA, Machalinski B and Gewirtz AM. (1998). Blood, 91, 1934-1946.
44. Rushton JJ, Davis LM, Lei W, Mo X, Leutz A and Ness SA. (2003). Oncogene, 22, 308-313.
45. Sala A, Casella I, Grasso L, Bellon T, Reed J, Miyashita T and Peschle C. (1996). Cancer Res., 56, 1991-1996.
46. Salvesen GS and Duckett CS. (2002). Nat. Rev. Mol. Cell Biol., 3, 401-410.
47. Sasaki H, Moriyama S, Yukiue H, Kobayashi Y, Nakashima Y, Kaji M, Fukai I, Kiriyama M, Yamakawa Y and Fujii Y. (2001). Lung Cancer, 1, 53-57.
48. Selvakumaran M, Liebermann DA and Hoffman Liebermann B. (1992). Mol. Cell Biol., 12, 2493-2500.
49. Seo SB, McNamara P, Heo S, Turner A, Lane WS and Chakravarti D. (2001). Cell, 104, 119-130.
50. Steingrimsson E, Tessarollo L, Pathak B, Hou L, Arnheiter H, Copeland NG and Jenkins NA. (2002). Proc. Natl. Acad. Sci. USA, 99, 4477-4482.
51. Sumner R, Crawford A, Mucenski M and Frampton J. (2000). Oncogene, 19, 3335-3342.
52. Taylor D, Badiani P and Weston K. (1996). Genes Dev., 10, 2732-2744.
53. Tewari M, Yu M, Ross B, Dean C, Giordano A and Rubin R. (1997). Cancer Res., 57, 4063-4069.
54. Tsukasaki K, Miller CW, Greenspun E, Eshaghian S, Kawabata H, Fujimoto T, Tomonaga M, Sawyers C, Said JW and Koeffler HP. (2001). Oncogene, 20, 3301-3305.
55. Vandenbark G, Chen Y, Friday E, Pavlik K, Anthony B, deCastro C and Kaufman R. (1996). Cell Growth Differ., 7, 1383-1392.
56. Weston K. (1998). Curr. Opin. Genet. Dev., 8, 76-81.
57. White JR and Weston K. (2000). Oncogene, 19, 1196-1205.
58. Wilkinson JC, Wilkinson AS, Scott FL, Csomos RA, Salvesen GS and Duckett CS. (2004). J. Biol. Chem., 279, 51082-51090.
59. Won KA, Schumacher RJ, Farr GW, Horwich AL and Reed SI. (1998). Mol. Cell Biol., 18, 7584-7589.
60. Yunta M and Lazo PA. (2003). Oncogene, 22, 1219-1224.
61. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, Ross J, Haug J, Johnson T, Feng JQ, Harris S, Wiedemann LM, Mishina Y and Li L. (2003). Nature, 425, 836-841.